Navigation Links
Not-so-sweet potato from Clemson University, USDA resists pests, disease
Date:6/21/2011

BLACKVILLE, S.C. Scientists from Clemson University and the USDA Agricultural Research Service have developed a new variety of not-so-sweet potato, called Liberty.

Known as a boniato, or tropical sweet potato, Liberty has a dark red skin and light yellow, dry flesh with a bland flavor. Boniato potatoes originated in the tropical Americas and are grown in south Florida in the United States. They can be served fried, mashed or in soup.

"We developed Liberty because other boniato varieties are susceptible to damage by nematodes (microscopic parasitic worms)," said John Mueller, plant pathologist and director of Clemson's Edisto Research and Education Center in Blackville.

Mueller worked with a team of scientists from the U.S. Vegetable Laboratory in Charleston led by entomologist Mike Jackson. Other USDA Agricultural Research Service team members included agronomist Howard Harrison, plant pathologist Judy Thies and plant geneticist Janice Bohac.

The Liberty potato is highly resistant to nematodes and moderately resistant to insect pests and fusarium wilt, a fungal disease. Liberty potatoes have good baking quality, store well and do not darken after peeling as most boniato potatoes do. Home gardeners, as well as commercial producers and organic growers, can grow the Liberty potato.


'/>"/>

Contact: John Mueller
jmllr@clemson.edu
803-284-3343 x273
Clemson University
Source:Eurekalert

Page: 1

Related biology news :

1. UC Riverside researcher receives $9 million USDA grant to study potato and tomato disease
2. Toward controlling fungus that caused Irish potato famine
3. Newco produces seed potatoes in the open air
4. Lose the weight, not the potatoes
5. Couch potatoes of the animal kingdom
6. Increasing potato production
7. Wild potato germplasm holds key to disease resistance
8. Scientists clarify origins of potato germplasm Neo-Tuberosum
9. ARS scientists in North Dakota help improve potato storage capabilities
10. New methods developed to detect, measure potato phytonutrients
11. Its elemental: Potato after-cooking darkening may be affected by nutrients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 15, 2014 Research and Markets ... addition of the "Samsung Galaxy S5 - ... report to their offering. ... totally different sensing technology than the iPhone 5S, ... sensor in its product. The Galaxy ...
(Date:12/17/2014)... YORK , Dec. 15, 2014  HITLAB ... Good Clinical Practices (GCP) audit to confirm its ... (FDA) regulations. This accomplishment enables HITLAB to conduct ... utilizing the highest principles for patient safety and ... improve global healthcare access, quality, and delivery with ...
(Date:12/17/2014)... 2014 Research and Markets ( ... "Global Chemical Sensor Market 2015-2019" report ... http://photos.prnewswire.com/prnh/20130307/600769 One major trend upcoming ... medical sensors in biomedical applications. Chemical sensors help ... correct diagnosis during surgical procedures. The Global Chemical ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... depression and other mood disorders may lie in a ... inhibit other cells) shown to contribute to symptoms like ... in a new study in the Journal of ... from depression and other mood disorders often react to ...
... Bethesda, MD -- According to new research published in ... zinc levels does not directly harm the blood vessel cells. ... which then circulates in the blood and causes harmful blood ... of zinc prevent the creation of this compound, but it ...
... was right when she warned you that loud music could ... gets damaged and how. In a research report published in ... , scientists describe exactly what type of damage noise ... compound that may prevent noise-related damage. ...
Cached Biology News:Penn study: Shutting off neurons helps bullied mice overcome symptoms of depression 2Potential diagnostic marker for zinc status offers insights into the effects of zinc deficiency 2Now hear this: Scientists discover compound to prevent noise-related hearing loss 2
(Date:12/24/2014)... 24, 2014  United Therapeutics Corporation (NASDAQ: ... (NYSE: MDT ) has submitted a ... Drug Administration (FDA) for the use of Medtronic,s ... (including a newly developed catheter) for use with ... intravenously to patients with pulmonary arterial hypertension.   ...
(Date:12/24/2014)... GMO corn cases filed across the ... in the process of being consolidated in a Kansas ... In Re: Syngenta AG MIR 162 Corn Litigation, MDL ... District of Kansas. , Management of the Syngenta GMO ... U.S. District Judge John W. Lungstrum.* , As a ...
(Date:12/24/2014)... The report provides basic ... definition, classification, application and industry overview. This ... and product cost structure. Production is separated ... also covers upstream raw materials, equipment, downstream ... and proposals. In the end, the export ...
(Date:12/24/2014)... Dec. 23, 2014 Vermillion, Inc. (Nasdaq: ... gynecologic disease, announced today that investors including Oracle ... Fund LLC and several Vermillion directors have agreed ... of Vermillion,s common stock and warrants to purchase ... private placement.  Under the terms ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5
... The following news advisory is being issued by MichBio: ... the meeting an important development for Michigan biosciences will ... for the bioscience industry When: Wednesday, May ... Dinner , 7:00 p.m. Meeting Purpose: The ...
... Programs; Agreement Underscores SAFC,s Commitment to Japan ... SAFC Hitech (R), a business segment within ... SIAL ), today underlined its commitment to Japan,s microelectronics industry ... industrial and medical gas producer, Air Water Inc ...
... acceptable primary endpoint, for a regulatory ... /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ... agreement with the U.S. Food and Drug Administration (FDA) ... trial of OGX-011, its lead product candidate targeting castrate ...
Cached Biology Technology:Key Industry-Relevant Development to be Announced at MichBio's 2009 Annual Meeting on May 6 2SAFC Hitech & Air Water Inc. Extend High-End Materials Research Services Collaboration to Support Japan Chip Industry 2SAFC Hitech & Air Water Inc. Extend High-End Materials Research Services Collaboration to Support Japan Chip Industry 3SAFC Hitech & Air Water Inc. Extend High-End Materials Research Services Collaboration to Support Japan Chip Industry 4SAFC Hitech & Air Water Inc. Extend High-End Materials Research Services Collaboration to Support Japan Chip Industry 5OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 2OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 3OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 4OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 5OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 6
...
... Peptide-Protein Conjugation, ... Bridges, Complex Peptides/Peptidomimetics, Special ... Phosphorylated/Biotinylated Structures, Peptide labeling AMC, ... -99%, fitting your needs, Chromogenic/Flurogenic ...
4-Hydroxy-3-nitrophenylacetyl hapten is conjugated to KLH (Keyhole Limpet Hemocyanin) lysine through amide bonds....
...
Biology Products: